The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commercial Development Agreement with Valkor

11 Apr 2022 08:28

RNS Number : 9285H
Quadrise Fuels International PLC
11 April 2022
 

11 April 2022

 

Quadrise Fuels International plc

("Quadrise," "QFI" or the "Company")

 

Commercial Development Agreement with Valkor Technologies LLC

 

Quadrise is pleased to announce the execution of a phased Commercial Development Agreement ("CDA") with Valkor Technologies LLC ("Valkor") headquartered in Park City, Utah, to commercialise Quadrise's MSAR® and bioMSAR™ technology at Valkor's projects in Utah state in the USA.

 

Under Phase 1 of the CDA, to be completed by 30 June 2022:

 

· Valkor will deliver a crude oil sample from a heavy oil asset in Utah in which they have an existing equity interest (the 'Primary Project') to Quadrise.

· Quadrise will perform analysis and testing on the sample to confirm that it is suitable to produce MSAR® and bioMSAR™.

· Quadrise and Valkor will together and in the same time frame:

o Negotiate supply agreements with identified target consumers of MSAR® and bioMSAR™ fuel to be produced by the Primary Project.

o Finalise the technical and operational requirements and commercial terms for license and supply of QFI technology.

Full commercial terms for an MSAR® and/or bioMSAR™ License and Supply Agreement at the Primary Project would then be concluded no later than October 2022.

 

Under Phase 2 of the CDA, following the conclusion of a License and Supply Agreement covering the Primary Project, Quadrise intends to grant Valkor exclusive terms over the deployment of QFI technology in the State of Utah. This is expected to take the form of further Licence and Supply Agreement(s) or Tolling Agreement(s) for projects on which QFI technology is proposed to be deployed.

 

Net profits generated under the License and Supply Agreement(s) or Tolling Agreement(s) are to be shared between Quadrise and Valkor, based on the respective contribution by each party to the deployment of QFI technology for each project.

Jason Miles, CEO of Quadrise Fuels International, commented:

"The need for more economical and lower carbon industrial and marine fuels has never been more apparent. Quadrise is delighted to have executed this agreement and looks forward to working expeditiously with the Valkor team to conclude commercial agreements for supply of MSAR® and bioMSAR™ for identified projects."

Steven Byle, CEO of Valkor, added:

"We are delighted to work jointly with Quadrise to secure high value opportunities for our Utah heavy sweet oil projects, following the successful testing completed on oil sands samples from the pilot plant last year. The supply and licensing of MSAR® technology in Utah is conditional on securing the first opportunity for fuel supply and offtake, and we look forward to working closely with Quadrise during the coming months on this commercial opportunity."

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

Notes to Editors

 

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

This announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFIFEESTILLIF
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSAGM Update
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.